20/20 Biolabs vs bioAffinity Technologies
AIDX and BIAF side by side, both in engineering, accounting, research, management, and related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AIDX and BIAF compare
20/20 Biolabs and bioAffinity Technologies are about the same size, with market caps of $2.6M and $2.6M.
20/20 Biolabs grew revenue faster over the last twelve months (16.7% versus −18.5% for bioAffinity Technologies).
20/20 Biolabs keeps more of each dollar of sales as profit, with a net margin of −183% compared with −279% at bioAffinity Technologies.
20/20 Biolabs scores higher on the StockData Score (6 against 5 for bioAffinity Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AIDX | BIAF |
|---|---|---|
| Size and price | ||
| Market cap | $2.6M | $2.6M |
| Share price | $0.204 | $2.20 |
| Change, 1 year | – | −93.2% |
| Beta (5Y) | – | −1.10 |
| Employees | 14 | 57 |
| StockData Score | ||
| Total score | 6 (better) | 5 |
| Valuation score | 3 | 3 |
| Growth score | 2 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.3× | 0.5× (better) |
| P/B | 1.6× | 0.7× (better) |
| FCF yield | – | −508% |
| Fair value | $0.535 | $11.85 |
| Margin of safety | 61.8% | 81.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 16.7% (better) | −18.5% |
| Profitability | ||
| Gross margin | 29.6% | – |
| Operating margin | −163% (better) | −246% |
| Net margin | −183% (better) | −279% |
| FCF margin | – | −236% |
| Return on equity | −239% (better) | −240% |
| Return on invested capital | – | −694% |
| Financial health | ||
| Debt / equity | – | 0.05 |
| Interest coverage | −21.3× (better) | −270.9× |
| Current ratio | 1.99 (better) | 1.51 |
| Altman Z-score | −8.88 (better) | −19.56 |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 4.2% | 11.1% |
| Held by insiders | 14.8% | – |
| Short interest, % of float | 0.52% | – |
Go deeper
- AIDX stock overview
- AIDX income statement
- AIDX valuation and score
- BIAF stock overview
- BIAF income statement
- BIAF valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.